219 related articles for article (PubMed ID: 16337151)
1. Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials.
Eisenberg E; McNicol ED; Carr DB
Eur J Pain; 2006 Nov; 10(8):667-76. PubMed ID: 16337151
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.
Eisenberg E; McNicol ED; Carr DB
JAMA; 2005 Jun; 293(24):3043-52. PubMed ID: 15972567
[TBL] [Abstract][Full Text] [Related]
3. Opioids for neuropathic pain.
McNicol ED; Midbari A; Eisenberg E
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD006146. PubMed ID: 23986501
[TBL] [Abstract][Full Text] [Related]
4. Opioids for neuropathic pain.
Eisenberg E; McNicol E; Carr DB
Cochrane Database Syst Rev; 2006 Jul; (3):CD006146. PubMed ID: 16856116
[TBL] [Abstract][Full Text] [Related]
5. [Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Sommer C; Welsch P; Klose P; Schaefert R; Petzke F; Häuser W
Schmerz; 2015 Feb; 29(1):35-46. PubMed ID: 25376548
[TBL] [Abstract][Full Text] [Related]
6. [Opioids in chronic low back pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Petzke F; Welsch P; Klose P; Schaefert R; Sommer C; Häuser W
Schmerz; 2015 Feb; 29(1):60-72. PubMed ID: 25503883
[TBL] [Abstract][Full Text] [Related]
7. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain.
McNicol E; Strassels SA; Goudas L; Lau J; Carr DB
Cochrane Database Syst Rev; 2005 Jan; (1):CD005180. PubMed ID: 15654708
[TBL] [Abstract][Full Text] [Related]
8. [Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration].
Schaefert R; Welsch P; Klose P; Sommer C; Petzke F; Häuser W
Schmerz; 2015 Feb; 29(1):47-59. PubMed ID: 25376547
[TBL] [Abstract][Full Text] [Related]
9. Methadone for chronic non-cancer pain in adults.
Haroutiunian S; McNicol ED; Lipman AG
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD008025. PubMed ID: 23152251
[TBL] [Abstract][Full Text] [Related]
10. Targeted pharmacotherapy of evoked phenomena in neuropathic pain: a review of the current evidence.
Granot R; Day RO; Cohen ML; Murnion B; Garrick R
Pain Med; 2007; 8(1):48-64. PubMed ID: 17244104
[TBL] [Abstract][Full Text] [Related]
11. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mu-opioid antagonists in the treatment of opioid-induced bowel dysfunction: systematic review and meta-analysis of randomized controlled trials.
McNicol E; Boyce DB; Schumann R; Carr D
Pain Med; 2008 Sep; 9(6):634-59. PubMed ID: 18828197
[TBL] [Abstract][Full Text] [Related]
13. Opioids and neuropathic pain.
Smith HS
Pain Physician; 2012 Jul; 15(3 Suppl):ES93-110. PubMed ID: 22786465
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.
King S; Forbes K; Hanks GW; Ferro CJ; Chambers EJ
Palliat Med; 2011 Jul; 25(5):525-52. PubMed ID: 21708859
[TBL] [Abstract][Full Text] [Related]
15. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
[TBL] [Abstract][Full Text] [Related]
16. Activation of Peripheral μ-opioid Receptors by Dermorphin [D-Arg2, Lys4] (1-4) Amide Leads to Modality-preferred Inhibition of Neuropathic Pain.
Tiwari V; Yang F; He SQ; Shechter R; Zhang C; Shu B; Zhang T; Tiwari V; Wang Y; Dong X; Guan Y; Raja SN
Anesthesiology; 2016 Mar; 124(3):706-20. PubMed ID: 26756519
[TBL] [Abstract][Full Text] [Related]
17. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects.
Furlan AD; Sandoval JA; Mailis-Gagnon A; Tunks E
CMAJ; 2006 May; 174(11):1589-94. PubMed ID: 16717269
[TBL] [Abstract][Full Text] [Related]
18. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.
Martell BA; O'Connor PG; Kerns RD; Becker WC; Morales KH; Kosten TR; Fiellin DA
Ann Intern Med; 2007 Jan; 146(2):116-27. PubMed ID: 17227935
[TBL] [Abstract][Full Text] [Related]
19. Long- or short-acting opioids for chronic non-malignant pain? A qualitative systematic review.
Pedersen L; Borchgrevink PC; Riphagen II; Fredheim OM
Acta Anaesthesiol Scand; 2014 Apr; 58(4):390-401. PubMed ID: 24617618
[TBL] [Abstract][Full Text] [Related]
20. Oxycodone and the challenge of neuropathic cancer pain: a review.
Núñez Olarte JM
Oncology; 2008; 74 Suppl 1():83-90. PubMed ID: 18758204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
